Cyclopharm Ltd (AU:CYC) — Stock Price
Cyclopharm Ltd (AU:CYC) is currently trading at AU$0.57 AUD, up 4.59% today. Over the past 52 weeks, shares have ranged between AU$0.46 and AU$1.23. This page tracks Cyclopharm Ltd's live share price on the AU exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Cyclopharm Ltd.
Cyclopharm Ltd (CYC) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Cyclopharm Ltd's daily closing share price and trading volume on the AU exchange over the past year, giving a clear view of recent price momentum and liquidity.
Cyclopharm Ltd Income Statement — Revenue, Profit & Earnings by Year
Cyclopharm Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | AU$32.33 Million | AU$27.57 Million | AU$26.34 Million | AU$23.22 Million | AU$17.70 Million |
| Cost of Revenue | AU$33.78 Million | AU$9.64 Million | AU$22.64 Million | AU$17.28 Million | AU$14.50 Million |
| Gross Profit | AU$-1.46 Million | AU$17.93 Million | AU$16.08 Million | AU$5.94 Million | AU$3.20 Million |
| Research & Development | AU$614.69K | AU$365.02K | AU$3.69 Million | AU$3.44 Million | AU$1.66 Million |
| SG&A | AU$26.23 Million | AU$21.48 Million | AU$14.00 Million | AU$10.96 Million | AU$10.79 Million |
| Total Operating Expenses | AU$16.72 Million | AU$32.28 Million | AU$13.72 Million | AU$13.22 Million | AU$9.64 Million |
| Operating Income | AU$-18.18 Million | AU$-14.35 Million | AU$-5.26 Million | AU$-7.28 Million | AU$-6.43 Million |
| EBITDA | AU$-16.41 Million | AU$-13.69 Million | AU$-3.84 Million | AU$-6.47 Million | AU$-5.79 Million |
| EBIT | AU$-18.18 Million | AU$-14.52 Million | AU$-4.77 Million | AU$-7.40 Million | AU$-6.55 Million |
| Interest Expense | AU$626.26K | AU$319.10K | AU$215.99K | AU$265.92K | AU$89.31K |
| Income Before Tax | AU$-17.86 Million | AU$-13.07 Million | AU$-4.19 Million | AU$-7.67 Million | AU$-6.64 Million |
| Income Tax Expense | AU$-636.78K | AU$126.17K | AU$511.08K | AU$581.67K | AU$693.29K |
| Net Income | AU$-17.22 Million | AU$-13.20 Million | AU$-4.70 Million | AU$-6.61 Million | AU$-5.04 Million |
Cyclopharm Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Cyclopharm Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | AU$46.10 Million | AU$62.13 Million | AU$45.91 Million | AU$49.54 Million | AU$55.74 Million |
| Total Current Assets | AU$28.46 Million | AU$42.39 Million | AU$30.20 Million | AU$36.87 Million | AU$43.25 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | AU$1.23 Million | — | — | — |
| Net Receivables | AU$8.59 Million | AU$7.50 Million | AU$7.90 Million | AU$7.71 Million | AU$8.04 Million |
| Inventory | AU$11.43 Million | AU$13.25 Million | AU$10.12 Million | AU$8.29 Million | AU$5.51 Million |
| Property, Plant & Equipment | AU$13.40 Million | AU$13.10 Million | AU$9.19 Million | AU$6.60 Million | AU$6.25 Million |
| Goodwill | AU$974.61K | AU$929.11K | AU$903.51K | AU$865.27K | AU$865.27K |
| Total Liabilities | AU$18.99 Million | AU$19.40 Million | AU$13.65 Million | AU$13.01 Million | AU$12.67 Million |
| Total Current Liabilities | AU$11.26 Million | AU$10.61 Million | AU$8.67 Million | AU$7.94 Million | AU$7.42 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | AU$8.29 Million | AU$-12.28 Million | AU$-7.50 Million | AU$-15.96 Million | AU$-24.74 Million |
| Total Stockholder Equity | AU$27.11 Million | AU$42.73 Million | AU$32.26 Million | AU$36.54 Million | AU$43.07 Million |
| Retained Earnings | AU$-65.08 Million | AU$-47.86 Million | AU$-34.66 Million | AU$-29.07 Million | AU$-21.58 Million |
Cyclopharm Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Cyclopharm Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | AU$-17.33 Million | AU$-12.57 Million | AU$-7.20 Million | AU$-5.68 Million | AU$-1.63 Million |
| Capital Expenditures | AU$1.99 Million | AU$971.86K | AU$538.00K | AU$1.55 Million | AU$1.16 Million |
| Free Cash Flow | AU$-19.32 Million | AU$-13.55 Million | AU$-7.74 Million | AU$-7.23 Million | AU$-2.79 Million |
| Investing Cash Flow | AU$3.00 Million | AU$-971.86K | AU$-508.47K | AU$-1.55 Million | AU$-1.16 Million |
| Financing Cash Flow | AU$-1.12 Million | AU$22.22 Million | AU$-1.02 Million | AU$-725.64K | AU$30.17 Million |
| Dividends Paid | — | AU$0.00 | AU$-884.83K | AU$882.59K | AU$881.32K |
| Stock-Based Compensation | — | AU$360.90K | AU$524.19K | AU$648.20K | AU$756.59K |
| Depreciation | AU$1.77 Million | AU$1.48 Million | AU$938.83K | AU$931.48K | AU$758.73K |
| Change in Cash | AU$-13.94 Million | AU$8.84 Million | AU$-8.57 Million | AU$-8.95 Million | AU$27.37 Million |
Cyclopharm Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Cyclopharm Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Feb 22, 2026 | -0.09 | — | — |
| Aug 24, 2025 | -0.07 | — | — |
| Mar 27, 2025 | -0.05 | 0.00 | — |
| Feb 20, 2023 | -0.04 | — | — |
| Aug 16, 2022 | -0.03 | — | — |
| Feb 23, 2022 | -0.01 | — | — |
| Aug 22, 2021 | -0.04 | — | — |
| Feb 24, 2021 | -0.01 | 0.00 | — |